A Phase IB Randomized Study of an Antiestrogen in Women With Newly Diagnosed Breast Cancer
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Tamoxifen (Primary) ; Arzoxifene
- Indications Early breast cancer
- Focus Biomarker; Pharmacodynamics
- 13 Jan 2017 Biomarkers information updated
- 09 Sep 2005 New trial record.